what does piramal pharma do

Piramal Pharma Limited operates as a global pharmaceutical company with three main segments: Contract Development and Manufacturing Organizations (CDMO), complex hospital generics, and consumer healthcare products. It provides services like injection and high-potency active pharmaceutical ingredients (HPAPI) and has a presence in over 100 countries with 17 manufacturing facilities.

what products does piramal pharma make

Piramal Pharma Limited makes products including complex hospital generics, particularly in critical care, and consumer healthcare over-the-counter (OTC) medicines. It also offers pharmaceutical services such as CDMO capabilities for drug development and manufacturing, including specialized areas like injection and HPAPI.

what sector is piramal pharma in

Piramal Pharma Limited operates in the pharmaceutical sector, specifically within the broader pharmaceutical industry, focusing on drug development, manufacturing, and distribution of finished pharmaceutical products and services.

when was piramal pharma founded

Piramal Pharma Limited was incorporated on March 4, 2020, and has been involved in the pharmaceutical space since its inception, though it expanded through acquisitions and organic growth starting from 1988 with the acquisition of Nicholas Laboratories.

PPL or Piramal Pharma Limited is a global pharmaceutical company offering a portfolio of differentiated pharma products and services, including CDMO, hospital generics, and consumer healthcare, with operations in over 100 countries and facilities in India, Europe, and North America.

Piramal Pharma Limited (PPLPHARMA) Share Price Today — ₹164.55

Piramal Pharma Limited (PPLPHARMA) live stock price is ₹164.55. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Piramal Pharma Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Piramal Pharma Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

PPLPHARMA

BSE

F&O

Piramal Pharma Limited

Healthcare· Pharmaceuticals & Biotechnology· INE0DK501011· Scrip: 543635

EN हिन्दी ગુજરાતી मराठी

₹164.55

▲ 4.30 (+0.00%)

2026-06-10

BSE

₹164.55

▲ 4.30

+0.00%

233 trading days · 1Y period

TODAY (BSE)

Open169.95

High170.20

Low163.00

Prev Close168.85

Volume62,929

Value₹1.1Cr

L: 163.00H: 170.20

Info

Face Value₹10

Listed2022-10-19

ISININE0DK501011

SeriesA

BSE Scrip543635

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue-1.67%

PAT-83.71%

EPS-82.35%

Profitability

EBITDA Margin18.7%

Net Margin0.2%

TTM EBITDA M.20.5%

TTM Net M.0.4%

Dividend

Yield—

Latest DPS₹0.14

Payout Ratio466.7%

Growth+27.27%

TTM Revenue

₹8949 Cr

TTM EBITDA

₹1833 Cr

TTM PAT

₹39 Cr

TTM EPS

₹0.30

Rev/Share

₹67.3

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	2204 Cr	2167 Cr	413 Cr	50 Cr	4 Cr	₹0.03
2024-09-30	2242 Cr	2200 Cr	500 Cr	103 Cr	23 Cr	₹0.17
2024-06-30	1951 Cr	2038 Cr	268 Cr	-67 Cr	-89 Cr	₹-0.67
2024-03-31	2552 Cr	2333 Cr	652 Cr	215 Cr	101 Cr	₹0.77
2023-12-31	1959 Cr	1982 Cr	307 Cr	5 Cr	10 Cr	₹0.08
2023-09-30	1911 Cr	1940 Cr	349 Cr	20 Cr	5 Cr	₹0.04
2023-06-30	1749 Cr	1909 Cr	162 Cr	-121 Cr	-99 Cr	₹-0.83
2023-03-31	2164 Cr	2101 Cr	421 Cr	87 Cr	50 Cr	₹0.42

Shareholding Pattern

CURRENT — 2026-03-31

Promoter34.9%

FII30.2%

DII15.6%

Public64.8%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-07-16	Dividend	Dividend - Re 0.14 Per Share
2024-07-12	Dividend	Dividend - Rs 0.11 Per Share
2023-08-02	Rights	Rights 5:46 @ Premium Rs 71/-

Earnings Transcripts

Transcript of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the...

30 Apr 2026NSE1K chars

Read →

Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) fo...

29 Apr 2026NSE1K chars

Read →

Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) fo...

29 Apr 2026NSE1K chars

Read →

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Investor Presentation

28 Apr 2026BSE46K chars

Read →

Piramal Pharma Limited has informed the Exchange about Investor Presentation

28 Apr 2026NSE46K chars

Read →

Piramal Pharma Limited has informed the Exchange about Investor Presentation

5 Nov 2025NSE29K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	169.00	170.36	162.15	164.07	13.00L
2026-06-03	168.00	169.30	164.71	167.01	23.00L
2026-05-27	178.90	179.58	173.80	174.24	24.81L
2026-05-26	180.00	180.72	175.40	178.86	21.24L
2026-05-25	176.10	180.70	175.25	179.46	29.36L
2026-05-22	176.50	177.55	174.60	175.63	14.59L
2026-05-21	177.39	178.00	174.52	176.08	19.83L
2026-05-20	172.80	177.00	170.20	176.35	27.97L
2026-05-19	176.07	178.90	172.32	173.23	27.00L
2026-05-18	174.00	176.27	170.30	175.08	23.94L
2026-05-15	174.71	179.36	171.52	174.87	32.71L
2026-05-14	178.15	179.06	173.41	174.56	57.24L
2026-05-13	177.50	181.34	176.07	177.39	35.11L
2026-05-12	184.15	184.70	175.10	176.56	59.93L
2026-05-11	177.80	188.40	176.04	184.15	1.39Cr
2026-05-08	183.50	185.47	178.30	179.85	61.85L
2026-05-07	166.70	196.44	165.10	183.73	5.13Cr
2026-05-06	161.20	167.00	159.52	165.19	55.29L
2026-05-05	160.50	161.65	157.77	159.92	23.33L
2026-05-04	163.34	163.96	159.45	160.30	17.44L
2026-04-30	161.47	162.90	156.14	161.87	34.41L
2026-04-29	163.25	168.67	159.36	160.15	65.91L
2026-04-28	170.00	171.47	163.50	164.47	60.16L
2026-04-27	166.29	171.65	165.08	168.78	94.89L
2026-04-24	164.68	167.90	163.60	165.47	1.28Cr
2026-04-23	153.81	168.50	153.30	163.87	5.24Cr
2026-04-22	150.71	154.98	150.00	153.81	28.26L
2026-04-21	149.00	151.99	148.90	150.81	23.00L
2026-04-20	149.49	150.05	146.02	148.79	17.55L
2026-04-17	148.00	149.69	146.85	148.85	21.66L

Frequently Asked Questions

About

Piramal Pharma Limited is a leading Indian pharmaceutical company that offers global Contract Development and Manufacturing Organization (CDMO) services, specializes in complex hospital generics, and produces consumer healthcare products, operating in over 100 countries from its 17 manufacturing facilities. The company's key offerings include a broad portfolio of APIs, formulated products, and advanced drug delivery systems, serving clients across therapeutic areas and geographies. Notably, Piramal Pharma has a significant market presence in the generics sector and has been expanding its CDMO capabilities to meet the growing demand for complex pharmaceutical manufacturing worldwide.

BOARD OF DIRECTORS

Subramanian Ramadorai

Independent Director

DEPARTED

Nathalie Leitch

Neeraj Bharadwaj

DEPARTED

Mutual Fund Holdings

2 funds · bar length = % to NAVBrowse all funds →

hdfc1 scheme

HDFC NIFTY SMALLCAP 250 INDEX FUND

0.50%

₹3 Cr